AnaptysBio Inc banner

AnaptysBio Inc
F:AN6

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
F:AN6
Watchlist
Price: 58.96 EUR -0.44% Market Closed
Market Cap: €1.6B

Wall St Price Targets

AN6 Price Targets Summary
AnaptysBio Inc

Wall Street analysts forecast AN6 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AN6 is 35.03 EUR with a low forecast of 22.21 EUR and a high forecast of 64.64 EUR.

Lowest Forecast
Price Target
22.21 EUR
62% Downside
Average Forecast
Price Target
35.03 EUR
41% Downside
Highest Forecast
Price Target
64.64 EUR
10% Upside
AnaptysBio Inc Competitors:
Price Targets
TCPC
BlackRock TCP Capital Corp
1% Upside
OFIX
Orthofix Medical Inc
44% Upside

Revenue
Forecast

28% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
28% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 22%.

Operating Income
Forecast

23% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
23% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 11 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 36%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AN6's stock price target?
Price Target
35.03 EUR

According to Wall Street analysts, the average 1-year price target for AN6 is 35.03 EUR with a low forecast of 22.21 EUR and a high forecast of 64.64 EUR.

What is the Revenue forecast for AnaptysBio Inc?
Projected CAGR
22%

Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 22%.

What is the Operating Income forecast for AnaptysBio Inc?
Projected CAGR
36%

Over the last 11 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 8 years is 36%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett